TWD 179.0
(-1.65%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 848.86 Million TWD | -28.44% |
2022 | 1.18 Billion TWD | 30.99% |
2021 | 905.64 Million TWD | 82.52% |
2020 | 496.18 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 833.27 Million TWD | -1.43% |
2024 Q2 | 781.44 Million TWD | -6.21% |
2023 Q4 | 848.86 Million TWD | -5.92% |
2023 FY | 848.86 Million TWD | -28.44% |
2023 Q1 | 1.02 Billion TWD | -11.78% |
2023 Q3 | 902.27 Million TWD | -5.18% |
2023 Q2 | 951.53 Million TWD | -7.12% |
2022 Q4 | 1.16 Billion TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Nang Kuang Pharmaceutical Co., Ltd. | 12.56 Million TWD | -6654.739% |
Maxigen Biotech Inc. | - TWD | -Infinity% |
SciVision Biotech Inc. | 346.69 Million TWD | -144.844% |
Bionime Corporation | 1.69 Billion TWD | 49.988% |
Pegavision Corporation | 365.09 Million TWD | -132.508% |